These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15177542)

  • 21. [Infectious gastroenteritis in relapses of inflammatory bowel disease. Therapeutic implications].
    Baliellas C; Xiol X; Barenys M; Saavedra J; Casanovas T; Iborra M; Sesé E
    Rev Esp Enferm Dig; 1996 Jun; 88(6):419-22. PubMed ID: 8755323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe?
    Reuter BK; Pizarro TT
    Eur J Immunol; 2004 Sep; 34(9):2347-55. PubMed ID: 15307167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The placebo effect in inflammatory bowel disease].
    Marín-Jiménez I
    Gastroenterol Hepatol; 2009 Oct; 32 Suppl 2():44-9. PubMed ID: 19900628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutritional issues and therapy in inflammatory bowel disease.
    Husain A; Korzenik JR
    Semin Gastrointest Dis; 1998 Jan; 9(1):21-30. PubMed ID: 9547853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease.
    Yukawa T; Oshitani N; Yamagami H; Watanabe K; Higuchi K; Arakawa T
    Int J Mol Med; 2007 Aug; 20(2):161-7. PubMed ID: 17611633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects.
    Papa A; Scaldaferri F; Danese S; Guglielmo S; Roberto I; Bonizzi M; Mocci G; Felice C; Ricci C; Andrisani G; Fedeli G; Gasbarrini G; Gasbarrini A
    Dig Dis; 2008; 26(2):149-55. PubMed ID: 18431065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation and coagulation in inflammatory bowel disease: The clot thickens.
    Danese S; Papa A; Saibeni S; Repici A; Malesci A; Vecchi M
    Am J Gastroenterol; 2007 Jan; 102(1):174-86. PubMed ID: 17100967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunotherapy of inflammatory bowel diseases].
    Wichan P; Chojnacki J; Wojtuń S
    Pol Merkur Lekarski; 2004; 17 Suppl 1():40-3. PubMed ID: 15603345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of antibiotics for treatment of inflammatory bowel disease.
    Nitzan O; Elias M; Peretz A; Saliba W
    World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
    Hedin C; Whelan K; Lindsay JO
    Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory bowel disease: the role of environmental factors.
    Danese S; Sans M; Fiocchi C
    Autoimmun Rev; 2004 Jul; 3(5):394-400. PubMed ID: 15288007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inflammatory bowel disease: IBD].
    Endo K; Shiga H; Kinouchi Y; Shimosegawa T
    Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of inflammatory bowel disease in patients with airways disease.
    Raj AA; Birring SS; Green R; Grant A; de Caestecker J; Pavord ID
    Respir Med; 2008 May; 102(5):780-5. PubMed ID: 18321696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug therapy for inflammatory bowel disease in pregnancy and the puerperium.
    Moffatt DC; Bernstein CN
    Best Pract Res Clin Gastroenterol; 2007; 21(5):835-47. PubMed ID: 17889811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of inflammatory bowel disease with corticosteroids.
    Katz JA
    Gastroenterol Clin North Am; 2004 Jun; 33(2):171-89, vii. PubMed ID: 15177533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
    Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
    Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoscopy/surveillance in inflammatory bowel disease.
    Ahmadi AA; Polyak S
    Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.
    Schultz M; Schölmerich J; Rath HC
    Dig Dis; 2003; 21(2):105-28. PubMed ID: 14571109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse models of inflammatory bowel disease.
    Byrne FR; Viney JL
    Curr Opin Drug Discov Devel; 2006 Mar; 9(2):207-17. PubMed ID: 16566291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory bowel disease therapy: an update.
    Shah SA; Peppercorn MA
    Compr Ther; 1995 Jun; 21(6):296-302. PubMed ID: 7664541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.